Literature DB >> 24928042

The nuclear retention signal of HPV16 L2 protein is essential for incoming viral genome to transverse the trans-Golgi network.

Stephen DiGiuseppe1, Malgorzata Bienkowska-Haba1, Lydia Hilbig1, Martin Sapp2.   

Abstract

The Human papillomavirus (HPV) capsid is composed of the major and minor capsid proteins, L1 and L2, respectively. Infectious entry requires a complex series of conformational changes in both proteins that lead to uptake and allow uncoating to occur. During entry, the capsid is disassembled and host cyclophilins dissociate L1 protein from the L2/DNA complex. Herein, we describe a mutant HPV16 L2 protein (HPV16 L2-R302/5A) that traffics pseudogenome to the trans-Golgi network (TGN) but fails to egress. Our data provide further evidence that HPV16 traffics through the TGN and demonstrates that L2 is essential for TGN egress. Furthermore, we show that cyclophilin activity is required for the L2/DNA complex to be transported to the TGN which is accompanied by a reduced L1 protein levels.
Copyright © 2014 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Cyclophilin; Entry; HPV; L1; L2; Trans-Golgi network

Mesh:

Substances:

Year:  2014        PMID: 24928042      PMCID: PMC4115330          DOI: 10.1016/j.virol.2014.04.024

Source DB:  PubMed          Journal:  Virology        ISSN: 0042-6822            Impact factor:   3.616


  47 in total

1.  Atomic model of the papillomavirus capsid.

Authors:  Yorgo Modis; Benes L Trus; Stephen C Harrison
Journal:  EMBO J       Date:  2002-09-16       Impact factor: 11.598

2.  Cleavage of the papillomavirus minor capsid protein, L2, at a furin consensus site is necessary for infection.

Authors:  Rebecca M Richards; Douglas R Lowy; John T Schiller; Patricia M Day
Journal:  Proc Natl Acad Sci U S A       Date:  2006-01-23       Impact factor: 11.205

3.  Characterization of a major neutralizing epitope on human papillomavirus type 16 L1.

Authors:  W I White; S D Wilson; F J Palmer-Hill; R M Woods; S J Ghim; L A Hewitt; D M Goldman; S J Burke; A B Jenson; S Koenig; J A Suzich
Journal:  J Virol       Date:  1999-06       Impact factor: 5.103

4.  Structure of small virus-like particles assembled from the L1 protein of human papillomavirus 16.

Authors:  X S Chen; R L Garcea; I Goldberg; G Casini; S C Harrison
Journal:  Mol Cell       Date:  2000-03       Impact factor: 17.970

5.  Generation of HPV pseudovirions using transfection and their use in neutralization assays.

Authors:  Christopher B Buck; Diana V Pastrana; Douglas R Lowy; John T Schiller
Journal:  Methods Mol Med       Date:  2005

6.  Preclinical model to test human papillomavirus virus (HPV) capsid vaccines in vivo using infectious HPV/cottontail rabbit papillomavirus chimeric papillomavirus particles.

Authors:  Andres F Mejia; Timothy D Culp; Nancy M Cladel; Karla K Balogh; Lynn R Budgeon; Christopher B Buck; Neil D Christensen
Journal:  J Virol       Date:  2006-09-27       Impact factor: 5.103

7.  Establishment of papillomavirus infection is enhanced by promyelocytic leukemia protein (PML) expression.

Authors:  Patricia M Day; Carl C Baker; Douglas R Lowy; John T Schiller
Journal:  Proc Natl Acad Sci U S A       Date:  2004-09-21       Impact factor: 11.205

8.  Human papillomavirus DNA replication compartments in a transient DNA replication system.

Authors:  C S Swindle; N Zou; B A Van Tine; G M Shaw; J A Engler; L T Chow
Journal:  J Virol       Date:  1999-02       Impact factor: 5.103

9.  Analysis of type-restricted and cross-reactive epitopes on virus-like particles of human papillomavirus type 33 and in infected tissues using monoclonal antibodies to the major capsid protein.

Authors:  M Sapp; U Kraus; C Volpers; P J Snijders; J M Walboomers; R E Streeck
Journal:  J Gen Virol       Date:  1994-12       Impact factor: 3.891

10.  Human papillomavirus type 31 uses a caveolin 1- and dynamin 2-mediated entry pathway for infection of human keratinocytes.

Authors:  Jessica L Smith; Samuel K Campos; Michelle A Ozbun
Journal:  J Virol       Date:  2007-07-11       Impact factor: 5.103

View more
  34 in total

Review 1.  Cruising the cellular highways: How human papillomavirus travels from the surface to the nucleus.

Authors:  Stephen DiGiuseppe; Malgorzata Bienkowska-Haba; Lucile G Guion; Martin Sapp
Journal:  Virus Res       Date:  2016-10-29       Impact factor: 3.303

Review 2.  Human Papillomavirus Entry: Hiding in a Bubble.

Authors:  Stephen DiGiuseppe; Malgorzata Bienkowska-Haba; Martin Sapp
Journal:  J Virol       Date:  2016-08-26       Impact factor: 5.103

3.  Incoming human papillomavirus type 16 genome resides in a vesicular compartment throughout mitosis.

Authors:  Stephen DiGiuseppe; Wioleta Luszczek; Timothy R Keiffer; Malgorzata Bienkowska-Haba; Lucile G M Guion; Martin J Sapp
Journal:  Proc Natl Acad Sci U S A       Date:  2016-05-17       Impact factor: 11.205

4.  Superinfection Exclusion between Two High-Risk Human Papillomavirus Types during a Coinfection.

Authors:  Jennifer Biryukov; Craig Meyers
Journal:  J Virol       Date:  2018-03-28       Impact factor: 5.103

5.  A Dual Role for the Nonreceptor Tyrosine Kinase Pyk2 during the Intracellular Trafficking of Human Papillomavirus 16.

Authors:  Elinor Y Gottschalk; Patricio I Meneses
Journal:  J Virol       Date:  2015-06-24       Impact factor: 5.103

Review 6.  HPV entry into cells.

Authors:  Pinar Aksoy; Elinor Y Gottschalk; Patricio I Meneses
Journal:  Mutat Res Rev Mutat Res       Date:  2016-09-23       Impact factor: 5.657

7.  Cell-Penetrating Peptide Mediates Intracellular Membrane Passage of Human Papillomavirus L2 Protein to Trigger Retrograde Trafficking.

Authors:  Pengwei Zhang; Gabriel Monteiro da Silva; Catherine Deatherage; Christopher Burd; Daniel DiMaio
Journal:  Cell       Date:  2018-08-16       Impact factor: 41.582

8.  Human Papillomavirus Major Capsid Protein L1 Remains Associated with the Incoming Viral Genome throughout the Entry Process.

Authors:  Stephen DiGiuseppe; Malgorzata Bienkowska-Haba; Lucile G M Guion; Timothy R Keiffer; Martin Sapp
Journal:  J Virol       Date:  2017-07-27       Impact factor: 5.103

9.  Furin Cleavage of L2 during Papillomavirus Infection: Minimal Dependence on Cyclophilins.

Authors:  Matthew P Bronnimann; Christine M Calton; Samantha F Chiquette; Shuaizhi Li; Mingfeng Lu; Janice A Chapman; Kristin N Bratton; Angela M Schlegel; Samuel K Campos
Journal:  J Virol       Date:  2016-06-24       Impact factor: 5.103

10.  Production of Furin-Cleaved Papillomavirus Pseudovirions and Their Use for In Vitro Neutralization Assays of L1- or L2-Specific Antibodies.

Authors:  Joshua W Wang; Ken Matsui; Yuanji Pan; Kihyuck Kwak; Shiwen Peng; Troy Kemp; Ligia Pinto; Richard B S Roden
Journal:  Curr Protoc Microbiol       Date:  2015-08-03
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.